TRANSCAN-3 launched its first Joint Transnational Call (JTC) for research proposals, co-funded by the European Commission (EC), in April 2021 (JTC2021). In the framework of this call, 28 funding organizations from 19 countries, together with the EC, joined forces to fund the best collaborative transnational research projects under the topic of "Next generation cancer immunotherapy: targeting the tumour microenvironment". Ultimately, 20 transnational consortia were selected for funding with a total budget of 25.9 million euros. This amount includes 8.5 million euro from EU contribution.
JTC 2021 Call statistics
The table below shows the number of countries and research groups for submitted pre-proposals, full proposals and funded projects. The overall success rate between the pre-proposals and the funded projects is 12%.
The graph below shows the gender distribution of coordinators for the funded projects. The gender distribution considering all research groups participating in the consortia shows instead a slightly different result, with 47% females and 53% males.
The following graph shows the cancer types that are studied in the framework of the funded projects. As illustrated, there is a wide variety of cancer types covered in awarded projects of this call, and a group of 5 projects focused on common cancer mechanisms and several cancer types.
The graph below displays the geographical distribution of the coordinators and partners in the funded projects. As depicted, coordinators come from 6 different countries, the partners come from 15 different countries, and there is a research group that will participate in a funded project that will not receive funding from the consortium.
The following graph presents the budget dedicated (M€) for the funded projects by funding organisations (FOs) , including EU Co-funding. The total budget requested for this call is 25.9 M€.